GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (NSE:VALIANTLAB) » Definitions » Total Long-Term Liabilities

Valiant Laboratories (NSE:VALIANTLAB) Total Long-Term Liabilities : ₹1,069 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Valiant Laboratories's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₹1,069 Mil.

Valiant Laboratories Total Long-Term Liabilities Historical Data

The historical data trend for Valiant Laboratories's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Total Long-Term Liabilities Chart

Valiant Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Long-Term Liabilities
18.45 609.25 617.49 767.49 1,069.32

Valiant Laboratories Quarterly Data
Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 767.49 - 1,074.99 - 1,069.32

Valiant Laboratories Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Valiant Laboratories Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (NSE:VALIANTLAB) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:540937 BOM:541400 BOM:532305 BOM:524790 BOM:524075 BOM:526953 BOM:530163 BOM:533543 BOM:532039 BOM:524731 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
543998:India
Address
Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Website
https://www.valiantlabs.in
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines